ES2187769T3 - Lactitol directamente comprensible y metodo de fabricacion del mismo. - Google Patents

Lactitol directamente comprensible y metodo de fabricacion del mismo.

Info

Publication number
ES2187769T3
ES2187769T3 ES97919075T ES97919075T ES2187769T3 ES 2187769 T3 ES2187769 T3 ES 2187769T3 ES 97919075 T ES97919075 T ES 97919075T ES 97919075 T ES97919075 T ES 97919075T ES 2187769 T3 ES2187769 T3 ES 2187769T3
Authority
ES
Spain
Prior art keywords
lactitol
granulate
physiologically acceptable
directly compressible
binder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97919075T
Other languages
English (en)
Other versions
ES2187769T5 (es
Inventor
Julita Pearson
Philip Olinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danisco Sweeteners Oy
Original Assignee
Danisco Sweeteners Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24875641&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2187769(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Danisco Sweeteners Oy filed Critical Danisco Sweeteners Oy
Application granted granted Critical
Publication of ES2187769T3 publication Critical patent/ES2187769T3/es
Publication of ES2187769T5 publication Critical patent/ES2187769T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Analogue/Digital Conversion (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNOS GRANULADOS DE LACTITOL DIRECTAMENTE COMPRESIBLES Y A UNOS COMPRIMIDOS DE LACTITOL FABRICADOS A PARTIR DE ESTOS GRANULADOS. LOS GRANULADOS CONTIENEN LACTITOLES Y UN LIGANTE NO CARIOGENO FISIOLOGICAMENTE ACEPTABLE, QUE PUEDE ESTAR CONSTITUIDO POR UN ALCOHOL DE AZUCAR NO CARIOGENO, UN AZUCAR REDUCTOR POLIMERIZADO, UNA CARBOXIMETILOCELULOSA ALCALINA, UN HIDROLIZADO DE ALMIDON HIDROGENADO, UNA HIDROXIPROPILCELULOSA, UN DERIVADO DE CELULOSA FISIOLOGICAMENTE ACEPTABLE, POLIVINILPIRROLIDONA, GOMA ARABIGA U OTRA GOMA FISIOLOGICAMENTE ACEPTABLE. EL LIGANTE PREFERIDO ES EL LACTITOL. ESTA INVENCION SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA OBTENCION DE LOS GRANULADOS DE LACTITOL DIRECTAMENTE COMPRESIBLES Y SE PUEDEN UTILIZAR EN EL PRENSADO DE COMPRIMIDOS. LOS COMPRIMIDOS OBTENIDOS DE ESTA MANERA TIENEN UNA DUREZA ELEVADA Y UNA FRIABILIDAD BAJA. SON NO CARIOGENOS Y POSEEN EL PERFIL DE SABOR Y LAS PROPIEDADES METABOLICAS DEL LACTITOL.
ES97919075T 1996-09-19 1997-09-16 Lactitol directamente compresible y metodo de fabricacion del mismo. Expired - Lifetime ES2187769T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US715825 1991-06-14
US08/715,825 US5846568A (en) 1996-09-19 1996-09-19 Directly compressible lactitol and method

Publications (2)

Publication Number Publication Date
ES2187769T3 true ES2187769T3 (es) 2003-06-16
ES2187769T5 ES2187769T5 (es) 2006-08-16

Family

ID=24875641

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97919075T Expired - Lifetime ES2187769T5 (es) 1996-09-19 1997-09-16 Lactitol directamente compresible y metodo de fabricacion del mismo.

Country Status (12)

Country Link
US (1) US5846568A (es)
EP (1) EP0938301B2 (es)
JP (1) JP2001502667A (es)
KR (1) KR20000036234A (es)
AT (1) ATE229797T1 (es)
AU (1) AU729040B2 (es)
CA (1) CA2263495A1 (es)
DE (1) DE69718046T3 (es)
ES (1) ES2187769T5 (es)
PL (1) PL332461A1 (es)
RU (1) RU2187999C2 (es)
WO (1) WO1998011878A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI107732B (fi) 1998-03-18 2001-09-28 Xyrofin Oy Laktitolin kiteyttäminen, kiteinen laktitolituote ja sen käyttö
NL1009350C2 (nl) * 1998-06-09 1999-12-10 Sara Lee De Nv Zoetstoftablet.
US20010055613A1 (en) * 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
US6384020B1 (en) * 1999-07-14 2002-05-07 Shire Laboratories, Inc. Rapid immediate release oral dosage form
DE19943491B4 (de) * 1999-09-10 2010-04-01 Südzucker AG Mannheim/Ochsenfurt Verbesserte Komprimate
US6872414B1 (en) 1999-09-20 2005-03-29 Xyrofin Oy Anhydrous lactitol crystals, a product containing the same and a process for the preparation thereof as well as use thereof
JP3419729B2 (ja) * 2000-03-16 2003-06-23 株式会社ファンケル 錠剤およびその製造方法
EP1133984B1 (en) * 2000-03-17 2005-05-11 Shin-Etsu Chemical Co., Ltd. Solid preparation containing low-substituted hydroxypropyl cellulose and production process thereof
WO2002100548A2 (en) * 2001-06-13 2002-12-19 Inhale Therapeutic Systems, Inc. Centrifuged rotating drum for treating cohesive powders
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US7682833B2 (en) * 2003-09-10 2010-03-23 Abbott Point Of Care Inc. Immunoassay device with improved sample closure
CN1686089B (zh) * 2005-05-08 2010-08-18 北京健健康康生物技术有限公司 一种可直接压片的木糖醇颗粒及其制备方法
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8846100B2 (en) * 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
CN108690101B (zh) 2010-11-19 2022-05-24 嘉吉公司 用于富集衍生自甜叶菊的糖苷组合物中的新蛇菊苷b和/或新蛇菊苷d的方法
CA2982270C (en) 2014-04-07 2023-01-10 Women & Infants Hospital Of Rhode Island Novel 7-dehydrocholesterol derivatives and methods using same
CN104447898B (zh) * 2014-11-06 2017-03-29 山东绿健生物技术有限公司 一种固体乳糖醇及其制备方法与应用
CN105030707B (zh) * 2015-07-10 2020-10-13 南京泽恒医药技术开发有限公司 一种基于改性葡萄糖全粉末直压法制备克霉唑含片的方法
US10806743B1 (en) 2017-05-12 2020-10-20 Braintree Laboratories, Inc. Method of administering lactitol to reduce plasma concentration of lactitol
US20200170291A1 (en) * 2017-05-23 2020-06-04 Particle Dynamics International, Llc Processes for producing lactitol granulates and granulates produced thereby

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536526A (en) * 1988-01-11 1996-07-16 Cultor Ltd. Xylitol-based binding and diluting agent and a process for the production thereof
US5021249A (en) * 1989-11-09 1991-06-04 Warner-Lambert Company Method of making a savory flavor granule and a free flowing savory flavor granule
GB8928196D0 (en) * 1989-12-13 1990-02-14 Merrell Dow Pharmaceuticals Li Pharmaceutical lozenges
US5204115A (en) * 1990-12-12 1993-04-20 Suomen Xyrofin Oy Directly compressible xylitol and method
JP3069458B2 (ja) * 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
US5651988A (en) † 1995-08-18 1997-07-29 Xyrofin Oy Combination osmotic and bulk forming laxatives

Also Published As

Publication number Publication date
EP0938301A1 (en) 1999-09-01
ES2187769T5 (es) 2006-08-16
AU4304297A (en) 1998-04-14
US5846568A (en) 1998-12-08
WO1998011878A1 (en) 1998-03-26
RU2187999C2 (ru) 2002-08-27
KR20000036234A (ko) 2000-06-26
AU729040B2 (en) 2001-01-25
JP2001502667A (ja) 2001-02-27
EP0938301B1 (en) 2002-12-18
EP0938301B2 (en) 2006-02-22
DE69718046T3 (de) 2006-10-26
PL332461A1 (en) 1999-09-13
DE69718046D1 (de) 2003-01-30
CA2263495A1 (en) 1998-03-26
DE69718046T2 (de) 2003-05-22
ATE229797T1 (de) 2003-01-15

Similar Documents

Publication Publication Date Title
ES2187769T3 (es) Lactitol directamente comprensible y metodo de fabricacion del mismo.
EE02969B1 (et) Otseselt kokkupressitav ksülitooli granulaat, selle valmistamise meetod ja tarbitav tablett
HUP0103886A2 (hu) Azonnali hatóanyag-kibocsátású, peptidalapú trombininhibitort tartalmazó tabletta, eljárás előállítására és alkalmazása
MX9806265A (es) TABLETA QUE CONTIENE EL ANTIBIOTICO beta-LACTAMA Y PRODUCCION DE LA MISMA.
AU7282896A (en) Solid medicaments obtained by extrusion of an isomalt-containing polymer-active substance melt
AU8046291A (en) Sucralfate chewable tablet
RU99105852A (ru) Прессуемый лактит и способ его получения
ES2052802T3 (es) Composiciones farmaceuticas solubles en la boca que contienen acetilcisteina.
PL329027A1 (en) Derivatives of benzopyrane exhibiting antagonistic activity in respect to leucotriene
CA2210321A1 (fr) Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
PL354258A1 (en) Preparation of sugar-free hard candy
JPH08157356A (ja) 口腔用錠剤
Taylor et al. Further observations on the auditory brainstem response in Duane's syndrome
CN106306315A (zh) 一种甲壳素美白口香糖及其制作方法
JPS6440423A (en) Patch for mucosa in oral cavity
NZ215654A (en) Non-sticking chewing gum containing hydrogenated starch, hydrolysate and carboxymethyl cellulose
EP1619965B1 (en) Edulcorant compositions
Highleyman US AIDS death rate decreases by nearly half
ATE202922T1 (de) Ophthalmische cromolyn-gelzubereitung
CA2151561A1 (en) Hydrazino and hydroxyamino-14.beta.-hydroxyandrostane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
HUT63412A (en) Process for producing acethylene derivatives substituted with chromanyl, thiochromanyl or tetrahydroquinolinyl group and heteromatic group and having retinoid-like activity, as well as pharmaceutical compositions comprising sqme as active ingredient
Ogasawara et al. Relation between Stimulating time duration and Loudness by Loudness Balance Method
HU9200677D0 (en) Physiologically active kanglemicine c, process for its production and use
CA2139399A1 (en) Redispersible Microdenominated Cellulose